375 related articles for article (PubMed ID: 7725227)
1. Vogt-Koyanagi-Harada syndrome.
Moorthy RS; Inomata H; Rao NA
Surv Ophthalmol; 1995; 39(4):265-92. PubMed ID: 7725227
[TBL] [Abstract][Full Text] [Related]
2. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features, risk factors and progresses on treatment of recurrent Vogt-Koyanagi-Harada disease].
Jia SS; Zhao C; Liu XS; Zhang MF
Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):317-320. PubMed ID: 28412807
[TBL] [Abstract][Full Text] [Related]
4. Vogt Koyanagi Harada disease: treatment and visual prognosis.
Alam M; Iqbal M; Khan BS; Hussain I
J Coll Physicians Surg Pak; 2013 Oct; 23(10):740-2. PubMed ID: 24112262
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Adalimumab for Chronic Vogt-Koyanagi-Harada Disease Refractory to Conventional Corticosteroids and Immunosuppressive Therapy and Complicated by Central Serous Chorioretinopathy.
Takayama K; Obata H; Takeuchi M
Ocul Immunol Inflamm; 2020 Apr; 28(3):509-512. PubMed ID: 31268769
[No Abstract] [Full Text] [Related]
7. Vogt-Koyanagi-Harada disease.
Read RW; Rao NA; Cunningham ET
Curr Opin Ophthalmol; 2000 Dec; 11(6):437-42. PubMed ID: 11141638
[TBL] [Abstract][Full Text] [Related]
8. Vogt-Koyanagi-Harada disease.
O'Keefe GA; Rao NA
Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
[TBL] [Abstract][Full Text] [Related]
9. [Vogt-Koyanagi-Harada disease].
Bonnet C; Daudin JB; Monnet D; Brézin A
J Fr Ophtalmol; 2017 Jun; 40(6):512-519. PubMed ID: 28579215
[TBL] [Abstract][Full Text] [Related]
10. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
11. Vogt-koyanagi-harada syndrome.
Fang W; Yang P
Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
[TBL] [Abstract][Full Text] [Related]
12. Vogt-Koyanagi-Harada disease.
Damico FM; Kiss S; Young LH
Semin Ophthalmol; 2005; 20(3):183-90. PubMed ID: 16282153
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH
Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284
[TBL] [Abstract][Full Text] [Related]
14. Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome.
Lertsumitkul S; Whitcup SM; Nussenblatt RB; Chan CC
Graefes Arch Clin Exp Ophthalmol; 1999 Dec; 237(12):1039-45. PubMed ID: 10654175
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Abu El-Asrar AM; Al Tamimi M; Hemachandran S; Al-Mezaine HS; Al-Muammar A; Kangave D
Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
[TBL] [Abstract][Full Text] [Related]
16. Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Yang P; Ye Z; Du L; Zhou Q; Qi J; Liang L; Wu L; Wang C; Kijlstra A
Curr Eye Res; 2018 Feb; 43(2):254-261. PubMed ID: 29111815
[TBL] [Abstract][Full Text] [Related]
17. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
Montero JA; Sanchis ME; Fernandez-Munoz M
J Neuroophthalmol; 2007 Mar; 27(1):36-40. PubMed ID: 17414871
[TBL] [Abstract][Full Text] [Related]
18. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
[TBL] [Abstract][Full Text] [Related]
19. Vogt-Koyanagi-Harada disease in Hispanic patients.
Sukavatcharin S; Tsai JH; Rao NA
Int Ophthalmol; 2007; 27(2-3):143-8. PubMed ID: 17380271
[TBL] [Abstract][Full Text] [Related]
20. Pathology of Vogt-Koyanagi-Harada disease.
Rao NA
Int Ophthalmol; 2007; 27(2-3):81-5. PubMed ID: 17435969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]